Form 4: Tempus AI Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Tempus AI Director David R. Epstein sold 370 shares of Class A Common Stock at $59.41 per share pursuant to a pre-arranged 10b5-1 trading plan.
Summary
- David R. Epstein, a Director of Tempus AI, Inc. (TEM), reported a transaction involving the company's Class A Common Stock.
- The transaction occurred on February 2, 2026, and involved the disposition of 370 shares.
- The shares were sold at a price of $59.41 per share.
- Following this transaction, David R. Epstein beneficially owns 26,051 shares of Class A Common Stock.
- The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly negative event. While it's an insider sale, the execution under a pre-arranged 10b5-1 plan mitigates the negative sentiment often associated with open-market insider selling, suggesting a planned personal financial move rather than a reaction to adverse company news.
Positives
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned sale rather than an immediate reaction to new information.
Negatives
- A director selling shares, even under a 10b5-1 plan, represents a reduction in direct insider ownership.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
StockSavvy.ai notes that insider sales, even when executed under a Rule 10b5-1 plan, are routinely monitored by investors as they can provide insights into management's personal financial planning and, in some cases, their long-term perspective on the company's valuation. However, the pre-planned nature often suggests personal liquidity management rather than a reaction to new corporate developments.
Stakeholder Impact
- Shareholders may note the director's sale, which could be interpreted as a minor signal regarding insider sentiment, though the 10b5-1 plan context typically reduces concern.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 02/02/2026 | Date of the reported transaction (sale of Class A Common Stock). |
| 02/04/2026 | Date the Form 4 was signed by the Attorney-in-Fact. |
Recommendation
holdThe sale by Director David R. Epstein of 370 shares of Tempus AI Class A Common Stock, executed under a Rule 10b5-1 trading plan, is a routine insider disclosure. While insider sales can sometimes signal a lack of confidence, the pre-planned nature mitigates this concern, suggesting a personal liquidity event rather than a change in fundamental outlook. This transaction alone does not provide sufficient new information to alter a fundamental investment thesis, thus a 'hold' recommendation is appropriate.
Keywords
Tempus AI, TEM, Form 4, Insider Trading, Stock Sale, Director, David R. Epstein, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.